stockrow
Friday 6 November 2026
Export KOD’s income statement to Excel — free account
Kodiak Sciences Inc.
- EPS
- −1.94%
- Free cash flow
- −33.9%
Quarter to June 2026, against a year earlier
98.85
7.83
+8.60%
Follow KOD
Alert me
Kodiak Sciences Inc. (KOD) Free cash flow
Kodiak Sciences Inc.'s free cash flow for fiscal 2025 was −$136.5M, compared with −$117.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$159.9M. Over the past ten years it has ranged from −$253.8M (fiscal 2022) to −$16.8M (fiscal 2016); the current reading is higher than 40% of that period. Kodiak Sciences Inc. ranks 515th of 603 Biotechnology companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$136.5M | — |
| FY2024 | −$117.7M | — |
| FY2023 | −$195.6M | — |
| FY2022 | −$253.8M | — |
| FY2021 | −$245.6M | — |
| FY2020 | −$90.4M | — |
| FY2019 | −$39.6M | — |
| FY2018 | −$29.6M | — |
| FY2017 | −$17.9M | — |
| FY2016 | −$16.8M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | −$46.6M | — |
| Mar 2026 | −$41.0M | — |
| Dec 2025 | −$39.4M | — |
| Sep 2025 | −$32.9M | — |
| 33 more quarters | Free account |
Against its own ten years
Low −$253.8M
High −$16.8M
Ten-year median
−$104.1M
Current reading's percentile
40
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| LGND Ligand Pharmaceuticals Incorporated compare | $79.8M |
| BLTE Belite Bio, Inc. Sponsored ADR compare | −$66.6M |
| ORKA Oruka Therapeutics, Inc. compare | −$101.2M |
| KOD Kodiak Sciences Inc. | −$159.9M |
| CGON CG Oncology, Inc. compare | −$179.3M |
| PTCT PTC Therapeutics, Inc. compare | −$259.2M |
| MIRM Mirum Pharmaceuticals, Inc. compare | −$308.9M |
| IMVT Immunovant, Inc. compare | −$414.3M |
| IONS Ionis Pharmaceuticals, Inc. compare | −$567.5M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)